ESSA Pharma Inc. announced that, pursuant to its stock option plan, it has granted incentive stock options to directors and officers, employees and consults of the Corporation to purchase up to an aggregate of 238,000 common shares in the capital of the Corporation.
April 12, 2019
· 5 min read